Clinical Trials
2 trialsNCT01380275 2014-09-25
Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.
National Cancer Center, Korea
Phase 2 Unknown
NCT00003719 2014-01-06
Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 2 Unknown